Geron Corporation (GERN) Estados Financieros e Histórico

Geron Corporation (GERN) — Precio $1.29 HealthcareBiotechnology — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Geron Corporation (GERN): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Geron Corporation registró ingresos de $183.9M en el último ejercicio fiscal, con un CAGR de 5 años del 273.5%.

Márgenes de los últimos 12 meses: margen bruto 83.2%, margen operativo -18.3%, margen neto -34.2%.

Al precio actual de $1.29, GERN presenta beneficios negativos (P/E no significativo) y un ROE del -30.31%. La capitalización bursátil es de $828M.

Cuenta de Resultados (10 años)

Año2016201720182019202020212022202320242025
Ingresos$6.2M$1.1M$1.1M$460000$253000$1.4M$596000$237000$77.0M$183.9M
Coste de Ventas$14.7M$8.4M$12.7M$51.3M$50.1M000$1.3M$4.7M
Beneficio Bruto-$8.5M-$7.4M-$11.7M-$50.8M-$49.8M$1.4M$596000$237000$75.7M$179.1M
I+D$18.0M$11.0M$13.4M$52.1M$51.5M$85.7M$95.5M$125.0M$103.7M$73.7M
Generales y Administrativos$18.8M$19.3M$18.7M$21.7M$27.1M$29.7M$43.6M$69.1M$145.7M$159.3M
Gastos Operativos$36.8M$30.3M$32.1M$21.7M$27.1M$115.4M$139.1M$194.2M$249.5M$233.0M
Beneficio Operativo-$30.6M-$29.3M-$31.1M-$72.5M-$76.9M-$114.0M-$138.6M-$193.9M-$173.7M-$53.8M
EBITDA-$30.6M-$29.2M-$27.0M-$72.4M-$76.8M-$111.6M-$134.2M-$174.8M-$154.8M-$51.9M
Gastos por Intereses$83000000$760000$3.7M$6.9M$8.3M$18.5M$32.7M
Beneficio Antes de Impuestos-$29.5M-$27.9M-$27.0M-$68.5M-$75.6M-$116.1M-$141.9M-$184.1M-$174.6M-$85.8M
Impuestos0000000000
Beneficio Neto-$29.5M-$27.9M-$27.0M-$68.5M-$75.6M-$116.1M-$141.9M-$184.1M-$174.6M-$85.8M
BPA$-0.19$-0.18$-0.15$-0.33$-0.28$-0.37$-0.37$-0.32$-0.27$-0.13
BPA Diluido$-0.19$-0.18$-0.15$-0.33$-0.28$-0.37$-0.37$-0.32$-0.27$-0.13
Acciones en Circulación (Diluidas)$159.0M$159.2M$176.5M$190.2M$271.5M$327.6M$380.8M$570.6M$646.0M$666.7M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos$47.2M$48.0M$51.8M$57.5M
Beneficio Bruto$25.1M$46.7M$50.1M$48.2M
Beneficio Operativo-$13.9M-$10.8M-$236000-$12.5M
EBITDA-$9.7M-$23.6M$3.8M-$12.4M
Beneficio Neto-$18.4M-$31.1M-$3.6M-$16.7M
BPA$-0.03$-0.05$-0.01$-0.02
BPA Diluido$-0.03$-0.05$-0.01$-0.02

Balance (10 años)

Año2016201720182019202020212022202320242025
Caja y Equivalentes$13.1M$16.6M$10.8M$13.6M$9.9M$34.9M$56.8M$70.0M$79.0M$79.4M
Inversiones a Corto$102.0M$78.4M$152.7M$125.7M$186.3M$148.9M$115.9M$263.7M$327.6M$280.4M
Cuentas por Cobrar$475000$436000$1.2M$802000$722000$1.8M$3.1M$1.7M$38.8M$39.2M
Inventario-$475000-$436000-$1.2M00000$38.7M0
Activos Corrientes$116.1M$96.0M$166.1M$141.6M$199.9M$187.2M$180.2M$341.3M$491.0M$520.3M
Inmovilizado Material$183000$102000$59000$2.9M$6.0M$5.4M$4.9M$4.7M$4.2M$884000
Fondo de Comercio0000000000
Activos Intangibles0000000000
Activos Totales$130.2M$110.3M$185.3M$165.5M$270.7M$226.0M$190.6M$394.1M$593.8M$570.5M
Cuentas por Pagar$225000$503000$982000$1.2M$6.9M$6.7M$10.2M$6.2M$8.6M$11.3M
Deuda a Corto000000$20.9M$46.9M0$18.4M
Pasivos Corrientes$7.9M$6.5M$7.6M$28.2M$30.9M$45.5M$76.7M$108.1M$88.3M$111.5M
Deuda a Largo0000$24.0M$49.8M$30.2M$35.1M$118.5M$231.7M
Pasivos Totales$7.9M$6.5M$7.6M$30.4M$59.8M$99.6M$110.6M$146.1M$313.5M$344.7M
Reservas-$957.9M-$985.8M-$1.01B-$1.08B-$1.16B-$1.27B-$1.41B-$1.60B-$1.77B-$1.86B
Patrimonio Neto$122.4M$103.8M$177.7M$135.2M$210.9M$126.4M$80.0M$247.9M$280.3M$225.9M
Deuda Total000$2.6M$29.7M$55.0M$55.8M$85.9M$121.7M$251.6M
Deuda Neta-$115.1M-$95.0M-$163.6M-$136.8M-$166.6M-$128.7M-$117.0M-$247.8M-$284.9M-$108.2M
Capital Circulante$108.2M$89.5M$158.5M$113.4M$168.9M$141.7M$103.6M$233.3M$402.7M$408.7M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$78.1M$79.4M$70.8M$62.6M
Activos Totales$567.4M$570.5M$534.1M$519.0M
Pasivos Totales$318.7M$344.7M$305.0M$300.4M
Patrimonio Neto$248.7M$225.9M$229.1M$218.6M
Deuda Total$121.9M$251.6M$251.8M$122.1M

Flujo de Caja (10 años)

Año2016201720182019202020212022202320242025
Beneficio Neto-$29.5M-$27.9M-$27.0M-$68.5M-$75.6M-$116.1M-$141.9M-$184.1M-$174.6M-$85.8M
Amortizaciones$81000$76000$59000$776000$935000$783000$868000$1.0M$1.2M$1.2M
Compensación en Acciones$8.2M$8.1M$6.4M$6.1M$6.9M$8.1M$8.0M$19.4M$31.3M$88000
Cambio en Capital Circulante$2.1M-$1.4M-$245000$19.1M$383000$10.5M$5.0M$6.1M-$68.4M-$68.5M
Flujo de Caja Operativo-$18.4M-$20.6M-$21.0M-$43.8M-$66.7M-$95.6M-$127.4M-$167.7M-$218.6M-$111.0M
Inversiones (CapEx)-$570000-$16000-$413000-$401000-$207000-$431000-$830000-$680000-$49000
Adquisiciones$1600000-$27.8M$339000$1.6M-$1.2M$179.5M00
Recompra de Acciones0000000000
Dividendos Pagados0000000000
Flujo de Caja Libre-$18.4M-$20.6M-$21.0M-$44.2M-$67.1M-$95.8M-$127.8M-$168.6M-$219.3M-$111.1M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo-$13.6M-$22.1M-$62.9M-$15.8M
Inversiones (CapEx)$89000-$32000-$252000-$223000
Flujo de Caja Libre-$13.5M-$22.1M-$63.2M-$16.1M
Dividendos Pagados0000
Compensación en Acciones$6.8M$7.4M$4.9M$4.9M

Crecimiento y Márgenes (10 años)

Año2016201720182019202020212022202320242025
Crecimiento Ingresos (anual)-82.7%+0.1%-56.8%-45.0%+450.6%-57.2%-60.2%+32386.9%+138.8%
Crecimiento Beneficio Neto (anual)+5.5%+3.2%-153.7%-10.3%-53.6%-22.2%-29.8%+5.2%+50.9%
Crecimiento BPA (anual)+5.3%+16.7%-120.0%+15.2%-32.1%+0.0%+13.5%+15.6%+51.9%
Cambio en Acciones (anual)+0.1%+10.9%+7.7%+42.8%+20.7%+16.2%+49.9%+13.2%+3.2%
Crecimiento FCF (anual)-11.6%-2.3%-110.4%-51.6%-42.8%-33.5%-31.9%-30.1%+49.3%
Margen Bruto-138.5%-692.2%-1093.5%-11046.1%-19683.4%100.0%100.0%100.0%98.4%97.4%
Margen Operativo-497.3%-2746.9%-2914.9%-15762.0%-30400.4%-8183.7%-23246.6%-81832.9%-225.6%-29.3%
Margen EBITDA-496.0%-2739.8%-2528.9%-15748.0%-30337.9%-8010.7%-22508.6%-73747.7%-201.1%-28.2%
Margen Neto-479.3%-2621.2%-2534.4%-14901.7%-29888.1%-8335.4%-23808.9%-77690.7%-226.7%-46.7%
Margen FCF-299.0%-1930.1%-1972.3%-9617.8%-26503.2%-6874.6%-21444.6%-71127.8%-284.8%-60.4%
Tasa Impositiva Efectiva-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%

Datos por Acción (10 años)

Año2016201720182019202020212022202320242025
FCF por Acción$-0.12$-0.13$-0.12$-0.23$-0.25$-0.29$-0.34$-0.30$-0.34$-0.17
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$159.0M$159.2M$176.5M$190.2M$271.5M$327.6M$380.8M$570.6M$646.0M$666.7M

Qué mirar en Biotech

La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.

Rentabilidad

Rentabilidad sobre capital-30.31%
Rentabilidad sobre capital invertido-8.32%
Rentabilidad sobre activos-13.47%
Margen bruto83.21%
Margen operativo-18.29%
Margen neto-34.17%

Salud financiera

Deuda / Patrimonio0.56
Ratio corriente6.92
Piotroski F-Score2
Altman Z-Score-2.15

Ratios Clave (10 años)

Año2016201720182019202020212022202320242025
P/E-10.89-10.00-6.67-4.12-5.68-3.30-6.54-6.59-13.11-10.15
P/VC2.692.760.991.912.053.1611.524.868.163.90
P/V53.43269.11165.58562.211706.02286.941546.145080.4329.704.79
Margen Bruto-138.5%-692.2%-1093.5%-11046.1%-19683.4%100.0%100.0%100.0%98.4%97.4%
Margen Operativo-497.3%-2746.9%-2914.9%-15762.0%-30400.4%-8183.7%-23246.6%-81832.9%-225.6%-29.3%
Margen Neto-479.3%-2621.2%-2534.4%-14901.7%-29888.1%-8335.4%-23808.9%-77690.7%-226.7%-46.7%

Empresas relacionadas: ARVN · AVBP · DAWN · LENZ · REPL · RZLT · SVRA

Explorar sector: Healthcare · Biotechnology

Más secciones de GERN: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones